Results 121 to 130 of about 128,444 (337)

Tetrandrine enhances radiosensitivity through the CDC25C/CDK1/cyclin B1 pathway in nasopharyngeal carcinoma cells [PDF]

open access: bronze, 2017
Jun Wang   +7 more
openalex   +1 more source

Tomotherapy for sinonasal teratocarcinosarcoma with SMARCA4 deletion and CTNNB1 mutation: A case report and literature review

open access: yesPrecision Radiation Oncology, Volume 9, Issue 4, Page 314-318, December 2025.
This study is the first to report an SNTCS patient with SMARCA4 deletion and CTNNB1 mutation who achieved 47 months of complete remission after TOMO radiotherapy in combination with chemotherapy, highlighting the breakthrough efficacy of TOMO in the treatment of SNTCS.
Siyu Xie   +8 more
wiley   +1 more source

Infiltrating B-cell subtypes and associated hub genes in nasopharyngeal carcinoma identified from integrated single-cell, bulk RNA-sequencing, and immunohistochemical data

open access: yesHereditas
Background Nasopharyngeal carcinoma (NPC) is associated with lymphocyte infiltration; however, the majority of research on NPC has focused on the role of T cells, with relatively little known about the roles of B cells and their subtypes.
Fangyan Zhong   +8 more
doaj   +1 more source

Test-retest reliability of a computer-assisted self-administered questionnaire on early life exposure in a nasopharyngeal carcinoma case-control study

open access: yesScientific Reports, 2018
We evaluated the reliability of early life nasopharyngeal carcinoma (NPC) aetiology factors in the questionnaire of an NPC case-control study in Hong Kong during 2014–2017.
Zhi-Ming Mai   +13 more
doaj   +1 more source

Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma [PDF]

open access: gold, 2019
Lirong Wu   +10 more
openalex   +1 more source

Alterations of the oral microbiome in patients reinfected with SARS‐CoV‐2 omicron variants

open access: yesVIEW, EarlyView.
We studied the oral microbiome (the community of microbes in the mouth) in people who were reinfected with the omicron variant of SARS‐CoV‐2 and compared it with healthy individuals and other respiratory illness groups. By sequencing tongue‐coating samples from large cohorts, we identified microbial shifts linked to Omicron reinfection and built a ...
Benchen Rao   +17 more
wiley   +1 more source

Tumour‐informed workflow to use ctDNA as a biomarker for risk of recurrence in head and neck cancer patients post‐treatment

open access: yesVIEW, EarlyView.
Our study presents a tumour‐informed circulating tumour DNA (ctDNA) workflow designed to enhance the detection of recurrence in head and neck cancer patients, addressing key challenges such as low ctDNA tumour fractions and tumour heterogeneity. Abstract Circulating tumour DNA (ctDNA) is a promising minimally invasive biomarker for monitoring treatment
Xiaomin Huang   +8 more
wiley   +1 more source

Occipital lymph node metastasis from nasopharyngeal carcinoma: a special case report and literature review

open access: yesChinese Journal of Cancer, 2016
Cervical lymph node metastasis is common in patients with nasopharyngeal carcinoma (NPC), but occipital lymph node metastasis in NPC patients has not yet been reported. In this case report, we describe an NPC patient with occipital lymph node metastasis.
Jing Yang   +6 more
doaj   +1 more source

Outcomes of patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy [PDF]

open access: gold, 2021
Shyh‐An Yeh   +13 more
openalex   +1 more source

Bionic nanobombs target nasopharyngeal carcinoma to enhance the efficacy of chemoradiotherapy by destroying DNA damage repair systems

open access: yesVIEW, EarlyView.
A bionic nanomedicine system with core–shell structure (Nm‐pAu/CP/KU) was constructed. PEGylated gold nanoparticles (pAu) were loaded with cisplatin (CP) and a radiochemotherapy sensitizer (KU‐60019) to form the core pAu/CP/KU, and homologous nasopharyngeal carcinoma cell membrane vesicles (Nm) were used as the shell.
Junhua Zhang   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy